Complete blood count to evaluate major depressive disorder and/or generalized anxiety disorder: A case-control study
Keywords:
Major depressive disorder, Generalized anxiety disorder, Complete blood count, Inflammatory markerAbstract
Purpose: The aim of this study was to evaluate the clinical diagnostic significance and ratios of complete blood count parameters in patients diagnosed with either or both disorders.
Patients and methods: This case-control study included 153 drug-naive patients who were diagnosed with either or both disorders and a matched control group comprised of 163 healthy individuals. The complete blood count parameters with their differentials were calculated and analyzed for all the patients. Moreover, logistic regression analysis was performed using binary logistic analysis.
Results: The cases showed a relatively higher basophil count (0.05 ± 0.09, P = 0.013) and basophil percentage (0.98 ± 1.21, P = 0.019) but a significantly lower lymphocyte count (2.17 ± 0.64, P = 0.035), eosinophil count (0.13 ± 0.14, P = 0.003), and eosinophil percentage (2.1 ± 1.82, P = 0.016). In addition, the odds of being a case is lower with a high lymphocyte count (OR = 0.69; P = 0.04), higher with a high basophil count (OR = 203.91; P = 0.01) and after adjusted logistic regression analysis, odds of being a case was lower with a higher red cell distribution width (odds ratio = 0.63; P < 0.001).
Conclusion: Several parameters were significantly associated with both major depressive and generalized anxiety disorders. However, larger, multicenter, prospective studies are needed to increase the representation of the data as well as to generalize the results.
References
U.S. Department of Health and Human Services, National Institute of Mental Health. Major depression [Internet]. 2022 [cited 2023 April 17]. Available from: https://www.nimh.nih.gov/health/statistics/major-depression
U.S. Department of Health and Human Services, National Institute of Mental Health. Generalized anxiety disorder [Internet]. 2022 [cited 2023 April 17]. Available from: https://www.nimh.nih.gov/health/statistics/generalized-anxiety-disorder
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, D.C.: American Psychiatric Association Publishing; 2013. https://doi.org/10.1007/s11019-013-9529-6
Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosoma Med. 2009;71(2):171-86. https://doi.org/10.1097/PSY.0b013e3181907c1b
Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206-15. https://doi.org/10.1016/j.bbi.2015.06.001
Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254-70. https://doi.org/10.1038/npp.2016.146
Kayhan F, Gündüz Ş, Ersoy SA, Kandeğer A, Annagür BB. Relationships of neutrophil–lymphocyte and platelet–lymphocyte ratios with the severity of major depression. Psychiatry Res. 2017;247:332-5. https://doi.org/10.1016/j.psychres.2016.11.016
Serafini G, Pompili M, Seretti ME, Stefani H, Palermo M, Coryell W, et al. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur Neuropsychopharmacol. 2013;23(12):1672-86. https://doi.org/10.1016/j.euroneuro.2013.06.002
Orum MH, Kara MZ, Egilmez OB. Mean platelet volume and neutrophil to lymphocyte ratio as parameters to indicate the severity of suicide attempt. J Immunoassay Immunochem. 2018;39(6):647-59. https://doi.org/10.1080/15321819.2018.1529682
Shafiee M, Tayefi M, Hassanian SM, Ghaneifar Z, Parizadeh MR, Avan A, et al. Depression and anxiety symptoms are associated with white blood cell count and red cell distribution width: a sex-stratified analysis in a population-based study. Psychoneuroendocrinology. 2017;84:101-8. https://doi.org/10.1016/j.psyneuen.2017.06.021
Cosci F, Mansueto G. Biological and clinical markers in panic disorder. Psychiatry Investig. 2019;16(1):27-36. https://doi.org/10.30773%2Fpi.2018.07.26
Graeff FG, Guimarães FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54(1):129-41. https://doi.org/10.1016/0091-3057(95)02135-3
Martínez-Botía P, Velasco A, Rolle V, Jiménez-Trevino L, De la Fuente-Tomás L, Bernardo Á, et al. Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts. Eur Neuropsychopharmacol. 2020;40:17-30. https://doi.org/10.1016/j.euroneuro.2020.06.006
Sekhon S, Gupta V. Mood disorder. Statpearls [Internet]. 2020 [cited 2023 April 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/32644337/
Cheng CK, Chan J, Cembrowski GS, van Assendelft OW. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol. 2004;10(1):42-53. https://doi.org/10.1532/lh96.04010
Uyar B, Ateş Budak E. Effects of major depressive disorder on monocytes, high-density lipoprotein (HDL) and monocyte to HDL ratio: a case-control study. Psychiatr Danub. 2022;34(4):687-94. https://doi.org/10.24869/psyd.2022.687
Özyurt G, Binici NC. Increased neutrophil-lymphocyte ratios in depressive adolescents is correlated with the severity of depression. Psychiatry Res. 2018;268:426-31. https://doi.org/10.1016/j.psychres.2018.08.007
Demir S, Atli A, Bulut M, İbiloğlu AO, Güneş M, Kaya MC, et al. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat. 2015;11:2253-8. https://doi.org/10.2147/NDT.S89470
Pine D, Klein R. Anxiety disorders. In: Thapar A, Pine D, Leckman J, Scott S, Snowling M, Taylor E, editors. Rutter's Child Adolesc. Psychiatry. 6th ed. Hoboken, NJ: John Wiley & Sons; 2015. p. 822-40.
Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs. 2005;65:1493-520. https://doi.org/10.2165/00003495-200565110-00004
Mitchell RHB, Goldstein BI. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry. 2014;53:274-96. https://doi.org/10.1016/j.jaac.2013.11.013
Fábián B, Horváth IF, Shemirani AH, Csiki Z. Depression and anxiety symptoms are associated with mean platelet volume in autoimmune disorders. Int J Environ Res Public Health. 2022;19(17):11006. https://doi.org/10.3390/ijerph191711006
Özyurt G, Binici NC. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in adolescent obsessive-compulsive disorder: does comorbid anxiety disorder affect inflammatory response? Psychiatry Res. 2019;272:311-5. https://doi.org/10.1016/j.psychres.2018.12.131
Uzun N, Akıncı MA. Hemogram parameters in childhood anxiety disorders: could anxiety disorders be related with inflammation? Med Hypotheses. 2021;146:110440. https://doi.org/10.1016/j.mehy.2020.110440
Gündüz N, Timur Ö, Erzincan E, Turgut C, Turan H, Akbey ZY. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and red cell distribution width in patients with diagnosis of major depressive disorder. Medeniyet Med J. 2017;32(4):230-37. https://dx.doi.org/10.5222/MMJ.2017.230
Almis BH, Aksoy I. Mean platelet volume level in patients with generalized anxiety disorder. Psychiatry Clin Psychopharmacol. 2018;28(1):43-7. https://doi.org/10.1080/24750573.2017.1385210
Bondade S, Adinarayan M, Bhat PP. Mean platelet volume in anxiety disorder: a case-control study. Open J Psychiatry Allied Sci. 2019;10(2):115-9. http://dx.doi.org/10.5958/2394-2061.2019.00025.9
Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185(2):320-6. https://doi.org/10.1016/j.atherosclerosis.2005.06.001
Hernández E, Lastra S, Urbina M, Carreira I, Lima L. Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder. Int Immunopharmacol. 2002;2(7):893-900. https://doi.org/10.1016/S1567-5769(02)00025-5
McLaughlin KA, Kubzansky LD, Dunn EC, Waldinger R, Vaillant G, Koenen KC. Childhood social environment, emotional reactivity to stress, and mood and anxiety disorders across the life course. Depress Anxiety. 2010;27(12):1087-94. https://doi.org/10.1002/da.20762
Monk C, Kovelenko P, Ellman LM, Sloan RP, Bagiella E, Gorman JM, et al. Enhanced stress reactivity in paediatric anxiety disorders: implications for future cardiovascular health. Int J Neuropsychopharm. 2001;4(2):199-206. https://doi.org/10.1017/S146114570100236X
Faravelli C, Sauro CL, Godini L, Lelli L, Benni L, Pietrini F, et al. Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry. 2012;2(1):13. https://doi.org/10.5498%2Fwjp.v2.i1.13
Culpepper L. Impact of anxious symptoms and comorbid anxiety disorders on functional impairment in depressed patients. J Clin Psychiatry. 2016;77(5):27718.
Seo HJ, Jung YE, Kim TS, Kim JB, Lee MS, Kim JM, et al. Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression. J Nerv Ment Dis. 2011;199(1):42-8. https://doi.org/10.1097/nmd.0b013e3182043b60
Fawcett J. Suicide and anxiety in DSM-5. Depress Anxiety. 2013;30:898-901.
Kessler RC, Sampson NA, Berglund P, Gruber MJ, Al-Hamzawi A, Andrade L, et al. Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys. Epidemiol Psychiatr Sci. 2015;24(3):210-26. https://doi.org/10.1017/s2045796015000189
Zhou Y, Cao Z, Yang M, Xi X, Guo Y, Fang M, et al. Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder. Sci Rep. 2017;7(1):40511. https://doi.org/10.1038/srep40511
Shim IH, Woo YS, Bahk WM. Associations between immune activation and the current severity of the “with anxious distress” specifier in patients with depressive disorders. Gen Hosp Psychiatry. 2016;42:27-31. https://doi.org/10.1016/j.genhosppsych.2016.07.003
Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, et al. Reduced venous blood basophil count and anxious depression in patients with major depressive disorder. Psychiatry Investig. 2016;13(3):321. https://doi.org/10.4306%2Fpi.2016.13.3.321
Koudouovoh-Tripp P, Sperner-Unterweger B. Influence of mental stress on platelet bioactivity. World J Psychiatry. 2012;2(6):134. https://doi.org/10.5498%2Fwjp.v2.i6.134
Ransing RS, Patil B, Grigo O. Mean platelet volume and platelet distribution width level in patients with panic disorder. J Neurosci Rural Pract. 2017;8(02):174-8. https://doi.org/10.4103/jnrp.jnrp_445_16
Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137-62. https://doi.org/10.1038/npp.2011.205
Faravelli C, Scarpato MA, Castellini G, Sauro CL. Gender differences in depression and anxiety: the role of age. Psychiatry Res. 2013;210(3):1301-3. https://doi.org/10.1016/j.psychres.2013.09.027
Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374-83. https://doi.org/10.1016/j.bbi.2007.01.010
Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25(2):221-9. https://doi.org/10.1016/j.bbi.2010.10.008
Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med. 2005;67(2):187-94. https://doi.org/10.1097/01.psy.0000149259.72488.09
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-41. https://doi.org/10.1016/j.biopsych.2008.11.029
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Abdulelah Almansour , Hussain J. Aljubran , Omar Bamalan , Abdullah Abuzaid , Mohammed AlSharit, Faris Alanazi , Mohammad Holdar , Khalid AlHarkan , Marwa Shafey
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
